These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 32431202)
1. NLRC5 promotes cell migration and invasion by activating the PI3K/AKT signaling pathway in endometrial cancer. Fan Y; Dong Z; Shi Y; Sun S; Wei B; Zhan L J Int Med Res; 2020 May; 48(5):300060520925352. PubMed ID: 32431202 [TBL] [Abstract][Full Text] [Related]
2. Notch2 regulates matrix metallopeptidase 9 via PI3K/AKT signaling in human gastric carcinoma cell MKN-45. Guo LY; Li YM; Qiao L; Liu T; Du YY; Zhang JQ; He WT; Zhao YX; He DQ World J Gastroenterol; 2012 Dec; 18(48):7262-70. PubMed ID: 23326131 [TBL] [Abstract][Full Text] [Related]
3. AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway. Zheng J; Liu C; Shi J; Wen K; Wang X Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913077 [TBL] [Abstract][Full Text] [Related]
4. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion. Shukla S; Maclennan GT; Hartman DJ; Fu P; Resnick MI; Gupta S Int J Cancer; 2007 Oct; 121(7):1424-32. PubMed ID: 17551921 [TBL] [Abstract][Full Text] [Related]
5. lncRNA LA16c‑313D11.11 modulates the development of endometrial cancer by binding to and inhibiting microRNA‑205‑5p function and indirectly increasing PTEN activity. Xin W; Zhao S; Han X; Zhao P; Yu H; Gao X; Li P; Wu Q; Ding J; Hua K Int J Oncol; 2020 Jul; 57(1):355-363. PubMed ID: 32319598 [TBL] [Abstract][Full Text] [Related]
6. [P2Y purinergic receptor activated PI-3K/Akt signaling pathway in regulation of growth and invasion of prostatic cancer]. Wang YX; Shi YH; Gong LH; Li Y; Heng WJ; You JF; Zhong HH; Fang WG Zhonghua Bing Li Xue Za Zhi; 2007 Oct; 36(10):681-6. PubMed ID: 18194602 [TBL] [Abstract][Full Text] [Related]
7. NLR family CARD domain containing 5 promotes hypoxia-induced cancer progress and carboplatin resistance by activating PI3K/AKT via carcinoembryonic antigen related cell adhesion molecule 1 in non-small cell lung cancer. Dong Y; Xu T; Li D; Guo H; Du X; Li G; Chen J; Wang B; Wang P; Yu G; Zhao X; Xue R Bioengineered; 2022 Jun; 13(6):14413-14425. PubMed ID: 36694434 [TBL] [Abstract][Full Text] [Related]
8. RUNX2 Plays An Oncogenic Role in Esophageal Carcinoma by Activating the PI3K/AKT and ERK Signaling Pathways. Lu H; Jiang T; Ren K; Li ZL; Ren J; Wu G; Han X Cell Physiol Biochem; 2018; 49(1):217-225. PubMed ID: 30138923 [TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor induces HCCR expression via PI3K/Akt/mTOR signaling in PANC-1 pancreatic cancer cells. Xu Z; Zhang Y; Jiang J; Yang Y; Shi R; Hao B; Zhang Z; Huang Z; Kim JW; Zhang G BMC Cancer; 2010 Apr; 10():161. PubMed ID: 20423485 [TBL] [Abstract][Full Text] [Related]
10. Nerve growth factor induces endothelial cell invasion and cord formation by promoting matrix metalloproteinase-2 expression through the phosphatidylinositol 3-kinase/Akt signaling pathway and AP-2 transcription factor. Park MJ; Kwak HJ; Lee HC; Yoo DH; Park IC; Kim MS; Lee SH; Rhee CH; Hong SI J Biol Chem; 2007 Oct; 282(42):30485-96. PubMed ID: 17666398 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of miRNA-196b expression inhibits the proliferation, migration and invasiveness of HepG2 cells while promoting their apoptosis via the PI3K/Akt signaling pathway. Xu F; Zhu F; Wang W; Gao W; Chen X; Yu C Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):159-164. PubMed ID: 32538764 [TBL] [Abstract][Full Text] [Related]
12. NLRC5 promotes tumorigenesis by regulating the PI3K/AKT signaling pathway in cervical cancer. Ling L; Chen J; Zhan L; Fu J; He R; Wang W; Wei B; Ma X; Cao Y Sci Rep; 2024 Jul; 14(1):15353. PubMed ID: 38961101 [TBL] [Abstract][Full Text] [Related]
13. Down-regulation of mir-27b promotes angiogenesis and fibroblast activation through activating PI3K/AKT signaling pathway. Sun F; Bi Q; Wang X; Liu J Wound Repair Regen; 2020 Jan; 28(1):39-48. PubMed ID: 31587435 [TBL] [Abstract][Full Text] [Related]
14. Cisplatin and PI3kinase inhibition decrease invasion and migration of human ovarian carcinoma cells and regulate matrix-metalloproteinase expression. Karam AK; Santiskulvong C; Fekete M; Zabih S; Eng C; Dorigo O Cytoskeleton (Hoboken); 2010 Aug; 67(8):535-44. PubMed ID: 20607860 [TBL] [Abstract][Full Text] [Related]
15. Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway. Lin L; Gao Y; Hu X; Ouyang J; Liu C BMC Womens Health; 2022 Nov; 22(1):470. PubMed ID: 36434592 [TBL] [Abstract][Full Text] [Related]
16. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation. Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608 [TBL] [Abstract][Full Text] [Related]
17. Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated β-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine. Zhang FY; Hu Y; Que ZY; Wang P; Liu YH; Wang ZH; Xue YX Int J Mol Sci; 2015 Oct; 16(10):23823-48. PubMed ID: 26473829 [TBL] [Abstract][Full Text] [Related]
18. Effect of siRNA-silencing of SALL2 gene on growth, migration and invasion of human ovarian carcinoma A2780 cells. Miao F; Zhang X; Cao Y; Wang Y; Zhang X BMC Cancer; 2017 Dec; 17(1):838. PubMed ID: 29228922 [TBL] [Abstract][Full Text] [Related]
19. MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR. Zhang S; Wang M; Li Q; Zhu P Cancer Biomark; 2017 Dec; 21(1):179-186. PubMed ID: 29081412 [TBL] [Abstract][Full Text] [Related]
20. BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway. Kang MH; Kim JS; Seo JE; Oh SC; Yoo YA Exp Cell Res; 2010 Jan; 316(1):24-37. PubMed ID: 19835871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]